The decision in focus
Need a prescribing clinician?
Price the care relationship and the prescription together. Membership alone cannot establish an affordable treatment budget.
Self-pay comparison
Compare self-pay telehealth, separate prescriber and pharmacy access routes without mistaking a membership fee for a treatment total.
The decision in focus
Price the care relationship and the prescription together. Membership alone cannot establish an affordable treatment budget.
The decision in focus
Ask whether that clinician can support the pharmacy route you are considering, including follow-up and future refills.
Having no insurance and having a plan that excludes a particular treatment can lead to different savings eligibility. State your actual coverage situation when requesting a cash quote. Do not assume a coupon, manufacturer offer or provider promotion applies simply because you plan to pay yourself. This guide does not assign a universal cash price.
Sesame’s $99 care charge bills every 28 days, while Ro’s $149 ongoing monthly care fee uses a different interval. Both exclude medication. Subtracting the headline amounts does not establish a monthly saving. Ask each service for the same prescribed product and supply period, then add tests, pharmacy charges and any other required services.
LillyDirect is a manufacturer access route relevant to a tirzepatide comparison, especially when you already have a clinician. Include the cost of that clinician relationship rather than treating it as free. Establish who handles refill requests, prescription changes and clinical questions before moving an order.
Amble’s stated lack of a separate membership charge does not identify a dependable all-in GLP-1 renewal total. Its reviewed injection pathway describes compounded medicines, which are not FDA-approved. Compare that preparation as its own clinical and purchasing decision; do not label a price difference as savings on an identical approved product.
Write down the amount due today, the next medication payment and ongoing care fees. If you cannot obtain one of those figures, mark the treatment total unknown. A useful shortlist includes a workable renewal budget and clear terms if prescribing is declined, not just an attractive checkout entry price.
We use public information, have not enrolled as patients and do not measure clinical quality or support speed. Individual eligibility, state access, prescription and current terms must be confirmed directly.
Compounded drugs are not FDA-approved. This comparison is not a treatment recommendation. See our commercial disclosure and comparison method.